Skip to main content

Advertisement

SpringerLink
Log in

A first Portuguese epidemiological survey of fungaemia in a university hospital

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

A prospective, observational study was conducted at the biggest Portuguese hospital, aiming to evaluate the epidemiology of bloodstream fungal infection. During a period of 12 months (2004), all yeasts isolated from the blood cultures of patients with fungaemia admitted at a university hospital of Porto were collected. Demographic and clinical data, as well as haematological and biochemical profiles, were registered. Antifungal susceptibility was evaluated. The incidence of fungaemia and nosocomial fungaemia were 2.7 and 2 per 1,000 hospital admissions, respectively. Blood strains from 117 patients were identified. Thirty-five percent of yeast isolates were Candida albicans, followed by C. parapsilosis (25.6%). The mortality rate associated with fungaemia was 39.3%; the highest values were found in patients with C. glabrata and C. tropicalis infection. Seventy-five percent of the fungaemia episodes were nosocomial, with 48% mortality; the main predisposing factors were parenteral nutrition, gastric protection with omeprazole, surgical drainage and the presence of central venous catheters (CVCs). Thrombocytopaenia, urinary catheter, gastrointestinal pathology and nosocomial fungaemia were independently associated with a poor outcome. Antifungal susceptibility testing showed high fluconazole resistance (15%), mostly in C. tropicalis. We observed a high incidence of nosocomial fungaemia with high mortality rates. Important predisposing factors were identified, deserving further investigation. Local surveillance is warranted to monitor the incidence of in vitro antifungal resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172–1177

    Article  Google Scholar 

  2. Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosupressed patients. Lancet Infect Dis 3:685–702

    Article  PubMed  Google Scholar 

  3. Tortorano AM, Kibbler C, Pemán J, Bernhardt H, Klingspor L, Grillot R (2006) Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27:359–366

    Article  PubMed  CAS  Google Scholar 

  4. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas PG, Thomas C, Reingold A, Rothrock G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW; Cryptococcal Active Surveillance Group (1999) Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 179:449–454

    Article  PubMed  CAS  Google Scholar 

  5. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42:1519–1527

    Article  PubMed  Google Scholar 

  6. Sanglard D, Odds FC (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2:73–85

    Article  PubMed  CAS  Google Scholar 

  7. Clark TA, Hajjed RA (2002) Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 15:569–574

    PubMed  Google Scholar 

  8. Hospenthal DR, Murray CK, Rinaldi MG (2004) The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn Microbiol Infect Dis 48:153–160

    Article  PubMed  CAS  Google Scholar 

  9. Clinical Laboratory Standards Institute (CLSI) (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts, 2nd edn. Approved standard M27-A2. National Committee for Clinical Laboratory Standards (NCCLS), Wayne, Pennsylvania

  10. Garner JS, Jarvis WR, Emori TG, Toran TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140

    Article  PubMed  CAS  Google Scholar 

  11. Pittet D, Li N, Woolson RF, Wenzel RP (1997) Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 24:1068–1078

    Article  PubMed  CAS  Google Scholar 

  12. Roberts FJ (1989) Definition of polymicrobial bacteremia. Rev Infect Dis 11:1029–1030

    PubMed  CAS  Google Scholar 

  13. World Health Organization (WHO) International statistical classification of diseases and related health problems, 10th revision, Version for 2007. Available online at: http://www.who.int/classifications/apps/icd/icd10online/

  14. Pfaller MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D, Chaturvedi V, Ghannoum MA, Odds FC, Rinaldi MG, Sheehan DJ, Troke P, Walsh TJ, Warnock DW (2006) Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 44:819–826

    Article  PubMed  CAS  Google Scholar 

  15. Pfaller MA, Diekema DJ, Messer SA, Hollis RJ, Jones RN (2003) In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. Antimicrob Agents Chemother 47:1068–1071

    Article  PubMed  CAS  Google Scholar 

  16. Amrutkar PP, Rege MD, Chen H, LaRocco MT, Gentry LO, Garey KW (2006) Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection 34:322–327

    Article  PubMed  CAS  Google Scholar 

  17. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP (1998) National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 31:327–332

    Article  PubMed  CAS  Google Scholar 

  18. Tortorano AM, Pemán J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Cantón E, Zimmermann K, Seaton S, Grillot R; ECMM Working Group on Candidaemia (2004) Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23:317–322

    Article  PubMed  CAS  Google Scholar 

  19. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133–163

    Article  PubMed  CAS  Google Scholar 

  20. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J; Brazilian Network Candidemia Study (2006) Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44:2816–2823

    Article  PubMed  CAS  Google Scholar 

  21. Bedini A, Venturelli C, Mussini C, Guaraldi G, Codeluppi M, Borghi V, Rumpianesi F, Barchiesi F, Esposito R (2006) Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 12:75–80

    Article  PubMed  CAS  Google Scholar 

  22. Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Jonhson EM, Perry JD, Sullivan DJ, Wilson JA (2003) Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 54:18–24

    Article  PubMed  CAS  Google Scholar 

  23. Pemán J, Cantón E, Gobernado M; Spanish ECMM Working Group on Candidemia (2005) Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 24:23–30

    Article  PubMed  Google Scholar 

  24. Beck-Sagué C, Jarvis WR; National Nosocomial Infections Surveillance System (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 167:1247–1251

    PubMed  Google Scholar 

  25. Sandven P (2000) Epidemiology of candidemia. Rev Iberoam Micol 17:73–81

    PubMed  CAS  Google Scholar 

  26. Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S; Japan invasive Mycosis Surveillance Study Group (2004) National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 53:283–289

    Article  PubMed  CAS  Google Scholar 

  27. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, Coffman S, Hollis RJ (2000) Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 44:747–751

    Article  PubMed  CAS  Google Scholar 

  28. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Ragel-Frausto MS, Rinaldi MG, Saiman OL, Wiblin RT, Wenzel RP; National Epidemiology of Mycoses Survey (NEMIS) Study Group (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186

    Article  PubMed  CAS  Google Scholar 

  29. Chen YC, Chang SC, Luh KT, Hsieh WC (2003) Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrobial Chemother 52:71–77

    Article  CAS  Google Scholar 

  30. Dóczi I, Dósa E, Hajdú E, Nagy E (2002) Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. J Med Microbiol 51:677–681

    PubMed  Google Scholar 

  31. Yapar N, Uysal U, Yucesoy M, Cakir N, Yuce A (2006) Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses 49:134–138

    Article  PubMed  Google Scholar 

  32. Cole GT, Halawa AA, Anaissie EJ (1996) The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 22(Suppl 2):S73–S88

    PubMed  Google Scholar 

  33. Chen TC, Chen YH, Tsai JJ, Peng CF, Lu PL, Chang K, Hsieh HC, Chen TP (2005) Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan. J Microbiol Immunol Infect 38:200–210

    PubMed  CAS  Google Scholar 

  34. Ben-Abraham R, Keller N, Teodorovitch N, Barzilai A, Harel R, Barzilay Z, Paret G (2004) Predictors of adverse outcome from candidal infection in a tertiary care hospital. J Infect 49:317–323

    Article  PubMed  CAS  Google Scholar 

  35. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678

    Article  PubMed  CAS  Google Scholar 

  36. Loeffler J, Stevens DA (2003) Antifungal drug resistance. Clin Infect Dis 36(suppl 1):S31–S41

    Article  PubMed  CAS  Google Scholar 

  37. St-Germain G, Laverdière M, Pelletier R, Bourgault AM, Libman M, Lemieux C, Noël G (2001) Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 39:949–953

    Article  PubMed  CAS  Google Scholar 

  38. Pina-Vaz C, Rodrigues AG, Costa-de-Oliveira S, Ricardo E, Mårdh PA (2005) Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. J Antimicrob Chemother 56:678–685

    Article  PubMed  CAS  Google Scholar 

  39. Sanglard D (2002) Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 5:379–385

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the project POCTI/SAU-ESP/61080/2004.

Author information

Authors and Affiliations

  1. Department of Microbiology, Faculty of Medicine, Porto University, Alameda Professor Hernani Monteiro, 4200, Porto, Portugal

    S. Costa-de-Oliveira, C. Pina-Vaz & A. Gonçalves Rodrigues

  2. Department of Microbiology, Hospital S. João, Alameda Professor Hernani Monteiro, 4200, Porto, Portugal

    C. Pina-Vaz

  3. Burn Unit, Department of Plastic and Reconstructive Surgery, Hospital S. João, Alameda Professor Hernani Monteiro, 4200, Porto, Portugal

    A. Gonçalves Rodrigues

  4. Institute of Biomedical Sciences Abel Salazar, ICBAS, University of Porto, Largo Professor Abel Salazar, no. 2, 4099-003, Porto, Portugal

    D. Mendonça

Authors
  1. S. Costa-de-Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Pina-Vaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Mendonça
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Gonçalves Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Costa-de-Oliveira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Costa-de-Oliveira, S., Pina-Vaz, C., Mendonça, D. et al. A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur J Clin Microbiol Infect Dis 27, 365–374 (2008). https://doi.org/10.1007/s10096-007-0448-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-007-0448-4

Keywords

Search

Navigation